+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years +
All Genders
ID06706102

Characterizing Extracellular Vesicles During CAR-T Cell Therapy and Neurological Side Effects in ICANS

Led by Centre Hospitalier Universitaire de Saint Etienne · Updated on 2026-09-30

60

Participants Needed

1

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying Immune Effector Cell-Associated Neurotoxicity Syndrome ICANS, a serious neurological complication linked to CAR-T cell therapy. The study aims to understand the role of extracellular vesicles EVs, which are tiny biological particles that communicate between cells and may affect the brains blood barrier during treatment. This research seeks to improve prevention and treatment of ICANS, which impacts patient outcomes. Participants who are receiving CAR-T cell treatment will be monitored over time. The study involves measuring and characterizing EVs in the blood and cerebrospinal fluid before and at several time points after treatment Days -7, 0, 1, 2, 5, 8, 15, 30, and 60. Techniques include flow cytometry, electron microscopy, Nanoparticle Tracking Analysis, and MRI scans to assess brain blood barrier changes. During the study, participants undergo biological tests, MRI scans, and neuropsychological assessments at specified intervals. Researchers will track EV levels and types in relation to ICANS occurrence, neurological damage, and sleep apnea syndrome. The study evaluates clinical neurological status and brain imaging results over a two-month period to gather detailed data on treatment effects and patient safety.

CONDITIONS

Brief Title

Temporal Characterization of Extracellular Vesicles During Cellular Therapy Using CAR-T Cells and During the Occurrence of Immune Effector Cell-Associated Neurotoxicity Syndrome

Research Team

E

Emilie CHALAYER, MD

H

Hélène RAINGARD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here